Bicara Therapeutics Inc. BCAX
19.21
(0.57)
(2.88%)
as of 25 Sep
- Market cap
- $1.3B
- P/E
- 0.0×
Follow BCAX
Insider Buys
alert about insiders buying in the last 12 month
| Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|
Current Ratio |
15.32 | 27.93 | 14.58 |
Net Debt/EBITDA |
5.78 | 5.95 | 2.67 |
Debt/Assets |
0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 |
Operating CF/Net income |
0.88 | 1.10 | 0.77 |
Capex/Depreciation |
(30.84) | (0.16) | (0.69) |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| 0.00% | (39.63%) | (30.88%) | |
| 0.00% | (18.28%) | (29.32%) | |
ROIC |
0.00% | (2,379.53%) | 0.00% |
Return on Tangible Assets |
(24.05%) | (14.03%) | (35.06%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(79.67) | (4.45) | (1.96) |
Cash per Share |
397.24 | 29.14 | 7.59 |
Shareholders Equity per Share |
(256.45) | 29.27 | 7.34 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
(256.45) | 29.27 | 7.34 |
Free Cash Flow |
(46.21) | (74.76) | (107.11) |
Working Capital |
215.99 | 484.54 | 393.10 |
Capital Expenditures |
(0.59) | (0.01) | (0.28) |
Net Current Asset Value |
(151.68) | 484.41 | 392.51 |
| Other line items | |||
Quick Ratio |
15.28 | 27.22 | 14.33 |
Depreciation/Fixed assets |
0.09 | 0.36 | 1.23 |
Cash ROIC |
(56.12%) | (7.63%) | (13.13%) |
Accounts Payable Turnover |
— | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 |
Operating CF per Share |
(78.66) | (4.45) | (1.95) |
Capex per Share |
(1.01) | 0.00 | (0.01) |
Average Payables |
— | 3.02 | 4.70 |
Average Assets |
— | 371.99 | 470.50 |
Average Common Equity |
— | 171.55 | 446.66 |
Capex to Sales |
0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% |
Columns are period end dates